| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $116.3M | +54.1% |
| R&D Expense | $86.1M | -27.6% |
| SG&A Expense | $142.5M | +30.7% |
| Operating Income | -$155.6M | +13.3% |
| Interest Expense | $59.0M | +3.8% |
| Income Tax | $0 | — |
| Net Income | -$209.2M | +10.4% |
| EPS (Basic) | -$2.03 | +42.3% |
| EPS (Diluted) | -$2.03 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $82.2M | -34.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $48.5M | +43.8% |
| Inventory | $65.6M | +86.4% |
| Current Assets | $201.1M | -18.5% |
| Total Assets | $205.8M | -17.0% |
| Current Liabilities | $156.2M | +69.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$135.5M | +22.5% |
| Investing Cash Flow | $42.5M | +424.4% |
| Financing Cash Flow | $50.5M | +54.8% |
| +42.3% |
| Total Liabilities |
| $660.8M |
| +15.6% |
| Stockholders' Equity | -$455.0M | -40.5% |